BE431133A - - Google Patents
Info
- Publication number
- BE431133A BE431133A BE431133DA BE431133A BE 431133 A BE431133 A BE 431133A BE 431133D A BE431133D A BE 431133DA BE 431133 A BE431133 A BE 431133A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- membrane
- covering
- membranes
- elements
- Prior art date
Links
- 239000012528 membrane Substances 0.000 claims description 26
- 239000003814 drug Substances 0.000 claims description 24
- 229940079593 drug Drugs 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 13
- 239000000126 substance Substances 0.000 claims description 10
- 102000011782 Keratins Human genes 0.000 claims description 9
- 108010076876 Keratins Proteins 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 108010068370 Glutens Proteins 0.000 claims description 8
- 235000021312 gluten Nutrition 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 5
- 230000008961 swelling Effects 0.000 claims description 5
- 239000001993 wax Substances 0.000 claims description 5
- 239000013060 biological fluid Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002966 varnish Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 239000008298 dragée Substances 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000012188 paraffin wax Substances 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 240000000972 Agathis dammara Species 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229920002871 Dammar gum Polymers 0.000 claims description 2
- 244000062730 Melissa officinalis Species 0.000 claims description 2
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 210000004051 gastric juice Anatomy 0.000 claims description 2
- 239000010439 graphite Substances 0.000 claims description 2
- 229910002804 graphite Inorganic materials 0.000 claims description 2
- 239000000865 liniment Substances 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 239000001913 cellulose Substances 0.000 claims 2
- 229930195733 hydrocarbon Natural products 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 240000005428 Pistacia lentiscus Species 0.000 claims 1
- 235000021355 Stearic acid Nutrition 0.000 claims 1
- 241000736873 Tetraclinis articulata Species 0.000 claims 1
- 229940110456 cocoa butter Drugs 0.000 claims 1
- 235000019868 cocoa butter Nutrition 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000003925 fat Substances 0.000 claims 1
- 235000019197 fats Nutrition 0.000 claims 1
- 239000013521 mastic Substances 0.000 claims 1
- 239000012907 medicinal substance Substances 0.000 claims 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 239000008117 stearic acid Substances 0.000 claims 1
- 239000010410 layer Substances 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 7
- 239000008188 pellet Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000006187 pill Substances 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 230000009172 bursting Effects 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000009950 felting Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000021189 garnishes Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- -1 nitro, acetyl Chemical group 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH848389X | 1937-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE431133A true BE431133A (enrdf_load_stackoverflow) |
Family
ID=4542057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE431133D BE431133A (enrdf_load_stackoverflow) | 1937-11-24 |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE431133A (enrdf_load_stackoverflow) |
| FR (1) | FR848389A (enrdf_load_stackoverflow) |
| NL (1) | NL52914C (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1172087A (fr) * | 1956-01-25 | 1959-02-05 | Bellon Labor Sa Roger | Perfectionnements concernant l'enrobage de préparations à effet retardé et à effet soutenu |
| GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
| US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
| US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
| EP1074249A1 (en) * | 1999-07-27 | 2001-02-07 | Jagotec Ag | A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period |
-
0
- BE BE431133D patent/BE431133A/fr unknown
- NL NL52914D patent/NL52914C/xx active
-
1938
- 1938-11-05 FR FR848389D patent/FR848389A/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL52914C (enrdf_load_stackoverflow) | |
| FR848389A (fr) | 1939-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1001101A5 (fr) | Forme de dosage pour le traitement des maladies cardiovasculaires. | |
| AU602931B2 (en) | Coating membrane and compositions prepared therefrom | |
| FR2914860A1 (fr) | Spheroides multicouches a action antipaludique dont l'une des couches contient de l'artesunate | |
| BE1000785A3 (fr) | Composition permettant d'administrer un medicament sous forme de gelules, d'une poudre ou d'un liquide. | |
| KR920008701B1 (ko) | 비대칭막을 사용한 전달수단 | |
| FR2523845A1 (fr) | Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose de poids moleculaire eleve | |
| FR2523442A1 (fr) | Dispositif therapeutique distribuant simultanement deux solutions pharmaceutiques | |
| EP0954290B1 (fr) | Comprime pharmaceutique a liberation controlee contenant un support a base d'amylose reticule et d'hydroxypropylmethylcellulose | |
| FR2523441A1 (fr) | Dispositif therapeutique osmotique pour la distribution de deux substances differentes | |
| CH683498A5 (fr) | Forme posologique pharmaceutique solide à libération programmée. | |
| WO2003045166A1 (fr) | Capsule a solubilisation et liberation du contenu rapides | |
| FR2480616A1 (fr) | Dispositif pour l'apport de substances par diffusion a un milieu environnant | |
| FR2572281A1 (fr) | Dispositif pour apporter un medicament au niveau du colon | |
| CH650405A5 (fr) | Produit pharmaceutique moule. | |
| EP0207041A2 (fr) | Comprimés pharmaceutiques permettant l'administration aisée de pellets, leur préparation et leur utilisation | |
| FR2723536A1 (fr) | Composition permettant une liberation selective d'un principe actif | |
| CA1327006C (en) | Process for preparing a retard product containing diltiazem for a single daily administration | |
| BE431133A (enrdf_load_stackoverflow) | ||
| DK2679216T3 (en) | Pharmaceutical form for modified release of betahistine | |
| FR2769854A1 (fr) | Nouveau procede d'obtention de microspheres et les produits ainsi realises | |
| BE897221A (fr) | Produits a effet prolonge contenant du suloctidil | |
| WO2010015754A1 (fr) | Composition pharmaceutique sous forme de granules et procede de fabrication d'une telle composition pharmaceutique | |
| EP2640364B9 (fr) | Composition pharmaceutique comprenant du sel de bicarbonate, et son utilisation comme médicament dans le traitement et/ou la prévention des lithiases urinaires et des maladies liées | |
| BE897863A (fr) | Nouvelle forme galenique du sulpiride, son procede de preparation et medicament comprenant cette nouvelle forme. | |
| TW201311296A (zh) | 新穎明膠膠囊組合物及其製備方法 |